Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,893 | 451 | 89.2% |
| Travel and Lodging | $922.56 | 3 | 9.3% |
| Education | $151.99 | 3 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,350 | 36 | $0 (2024) |
| Novo Nordisk Inc | $1,324 | 67 | $0 (2024) |
| GE Healthcare | $922.56 | 3 | $0 (2018) |
| Lilly USA, LLC | $591.57 | 34 | $0 (2024) |
| ABBVIE INC. | $499.33 | 34 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $455.64 | 27 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $447.19 | 24 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $424.61 | 22 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $379.13 | 20 | $0 (2024) |
| PFIZER INC. | $342.45 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,555 | 66 | AstraZeneca Pharmaceuticals LP ($304.65) |
| 2023 | $1,909 | 87 | AstraZeneca Pharmaceuticals LP ($320.38) |
| 2022 | $1,454 | 70 | Novo Nordisk Inc ($300.91) |
| 2021 | $1,421 | 66 | AstraZeneca Pharmaceuticals LP ($278.75) |
| 2020 | $730.11 | 44 | Lilly USA, LLC ($156.41) |
| 2019 | $652.16 | 43 | SANOFI-AVENTIS U.S. LLC ($119.99) |
| 2018 | $1,502 | 38 | GE Healthcare ($922.56) |
| 2017 | $743.48 | 43 | Novo Nordisk Inc ($201.03) |
All Payment Transactions
457 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: PSYCHIATRY | ||||||
| 12/06/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/03/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $30.58 | General |
| 11/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Diabetes | ||||||
| 11/16/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.91 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $43.22 | General |
| 11/08/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Cardio-renal | ||||||
| 10/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: UROLOGY | ||||||
| 10/15/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: UROLOGY | ||||||
| 10/08/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: PSYCHIATRY | ||||||
| 09/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Cardio-renal | ||||||
| 09/19/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: DERMATOLOGY | ||||||
| 09/12/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $28.55 | General |
| Category: UROLOGY | ||||||
| 08/29/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: PAIN | ||||||
| 08/25/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: PSYCHIATRY | ||||||
| 08/23/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $29.43 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Diabetes | ||||||
| 08/08/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $30.88 | General |
| Category: PSYCHIATRY | ||||||
| 08/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: PSYCHIATRY | ||||||
| 08/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 658 | 1,096 | $116,305 | $62,105 |
| 2022 | 13 | 548 | 985 | $113,683 | $58,660 |
| 2021 | 10 | 430 | 816 | $93,644 | $38,781 |
| 2020 | 8 | 442 | 1,054 | $122,883 | $41,481 |
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 132 | 330 | $31,324 | $17,712 | 56.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 82 | 149 | $26,671 | $11,937 | 44.8% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 85 | 142 | $17,716 | $10,176 | 57.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 69 | 69 | $12,627 | $8,455 | 67.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 52 | 52 | $6,098 | $3,220 | 52.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 48 | $6,061 | $2,729 | 45.0% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 19 | 19 | $4,006 | $2,651 | 66.2% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 28 | 56 | $3,360 | $1,647 | 49.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 16 | $4,000 | $1,551 | 38.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 40 | 40 | $1,040 | $730.00 | 70.2% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 12 | 12 | $540.00 | $401.88 | 74.4% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Office | 2023 | 11 | 12 | $1,608 | $341.88 | 21.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 25 | 33 | $660.00 | $334.47 | 50.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 34 | 34 | $216.25 | $211.93 | 98.0% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 17 | 84 | $378.00 | $7.74 | 2.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 88 | 183 | $32,757 | $16,024 | 48.9% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 86 | 168 | $21,000 | $11,909 | 56.7% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 115 | 222 | $21,090 | $11,408 | 54.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 55 | 86 | $10,922 | $4,513 | 41.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 26 | 32 | $8,000 | $4,120 | 51.5% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 30 | 30 | $6,810 | $3,804 | 55.9% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 27 | 28 | $4,956 | $2,729 | 55.1% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Facility | 2022 | 31 | 58 | $3,480 | $1,855 | 53.3% |
| 99304 | Initial nursing facility visit per day, typically 25 minutes | Facility | 2022 | 22 | 22 | $2,706 | $1,262 | 46.6% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2022 | 14 | 14 | $610.00 | $435.69 | 71.4% |
About Dr. Richard Wright, MD
Dr. Richard Wright, MD is a Internal Medicine healthcare provider based in Riverdale, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1770573552.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Wright, MD has received a total of $9,967 in payments from pharmaceutical and medical device companies, with $1,555 received in 2024. These payments were reported across 457 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($8,893).
As a Medicare-enrolled provider, Wright has provided services to 2,078 Medicare beneficiaries, totaling 3,951 services with total Medicare billing of $201,026. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Riverdale, GA
- Active Since 10/24/2005
- Last Updated 03/12/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1770573552
Products in Payments
- BREZTRI (Drug) $682.89
- Saxenda (Drug) $485.19
- Kerendia (Drug) $424.61
- REXULTI (Drug) $385.06
- FARXIGA (Drug) $382.71
- ENTRESTO (Drug) $345.38
- VRAYLAR (Drug) $304.13
- ELIQUIS (Drug) $289.34
- HETLIOZ (Drug) $268.25
- XARELTO (Drug) $251.41
- TRULICITY (Drug) $235.62
- MOUNJARO (Drug) $230.74
- Ozempic (Drug) $228.05
- NURTEC ODT (Drug) $223.36
- SOLIQUA 100/33 (Biological) $167.70
- Rybelsus (Drug) $144.27
- UBRELVY (Drug) $138.23
- Tresiba (Drug) $125.28
- JARDIANCE (Drug) $125.09
- AIRSUPRA (Drug) $122.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Riverdale
Dr. Victor Okeh, M.d, M.D
Internal Medicine — Payments: $21,812
Sureshkumar Muttath, M.d, M.D
Internal Medicine — Payments: $15,838
Paul Harvey, Md, MD
Internal Medicine — Payments: $9,729
Reva Gill, Md, MD
Internal Medicine — Payments: $5,883
Mr. Rao Mikkilineni, M.d, M.D
Internal Medicine — Payments: $5,799
Eduardo Flores, Md, MD
Internal Medicine — Payments: $5,613